noscript

News and Announcements

Atomo Diagnostic Annual Update 2016; US$3.4M Equity Raise & Grant from Bill & Melinda Gates Foundation

  • Published January 18, 2017 2:23PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Atomo Diagnostics is a multi-award winning and rapidly growing medical device company that has developed and commercialised AtomoRapid™,the world’s first integrated device for blood based immunoassay rapid diagnostic testing in point of care settings.  Atomo had many success to celebrate during 2016;

  • They successfully secured capital during 2016 via an equity raise for US$3.4m, with the Global Health Investment Fund (GHIF). Additionally the company secured a further US$2.6m in from non-dilutive grant funding from the Bill & Melinda Gates Foundation.
  • Atomo also entered agreements to supply award-winning, AtomoRapid devices to other diagnostics company’s.
  • These two deals involving a French and a Mexican company are expected to generate more than US$5M in product revenues over the life of the contracts.

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now